#VidaPlans20MChinaStockDipBuy

‍#Vida计划2000万美元抄底中国资产
20 Million Ready for China's Dip: Is This Conviction or a Falling-Knife Trade?

When markets are falling, one of the most interesting signals is seeing someone with significant capital choose to buy instead of waiting for everyone else to become confident.

Formula founder Vida has reportedly set aside around $20 million to invest in Chinese assets. He has already started buying Zhongji Innolight, CQQQ and Tencent, and says he is prepared to add more if prices decline further.

That certainly attracts attention. But I would separate two things: an investor seeing an attractive opportunity and the market actually reaching its bottom.

They are not the same.

1. Why this buying plan is attracting attention

The reported strategy is based partly on the idea that forced selling has created opportunities.

When leveraged investors face losses or margin pressure, they may have to sell positions regardless of whether the underlying businesses have changed fundamentally. That can push prices below levels some long-term investors consider reasonable.

Vida reportedly pointed to a sharp decline in China's growth-oriented stocks and suggested that a rapid rebound could follow, similar to a previous recovery in South Korea's market.

It is an interesting comparison, but historical rebounds are not a reliable timetable for the next one.

A market can fall sharply, recover briefly and then make another low. The amount of capital waiting to buy does not remove that possibility.

2. Three positions, three different investment stories

The interesting part is that these are not identical bets.

Zhongji Innolight: This is an AI infrastructure exposure. The company produces optical transceivers used in data centres, where fast data transmission is essential. Its business benefits from AI infrastructure demand, but it also faces valuation risk, competition and exposure to international trade restrictions.

Recent reporting has highlighted how sharply Chinese AI and semiconductor stocks have corrected. Some companies have fallen more than 50% from their earlier peaks, but a large decline alone does not prove that valuations are attractive.

CQQQ: This is a China technology-focused ETF, giving exposure to a broader group of Chinese technology companies rather than relying on one individual stock. That can spread company-specific risk, but it does not eliminate the risk of a wider decline across Chinese technology shares.

Tencent: This is a different kind of exposure. Tencent has major businesses across gaming, social platforms, advertising and financial technology. Its investment case is not identical to that of an AI hardware manufacturer.

For me, the distinction matters. Buying a diversified technology ETF, a data-centre component supplier and a large internet company represents three different risk profiles.

3. Why the market may still have room to fall

There are several reasons I would avoid treating this as a confirmed bottom.

First, valuation risk remains important. Chinese AI and technology stocks attracted substantial investor attention during the previous rally. Even after a correction, some valuations may still assume strong future growth.

Second, geopolitical risk has not disappeared. Restrictions on technology exports, overseas market access and supply chains can affect companies that depend on international customers.

Third, economic demand matters. A recovery in stock prices is more sustainable when earnings, domestic consumption and business confidence improve—not simply when selling pressure becomes exhausted.

Finally, capital flows can change quickly. One investor's willingness to deploy $20 million does not guarantee that other investors will follow.

4. The advantage of buying in stages

There is one part of this strategy worth examining: deploying capital gradually instead of committing everything at once.

If prices continue falling, staged buying can leave capital available for later opportunities. If the market stabilizes, earlier purchases provide some exposure to a recovery.

But averaging down has a risk of its own. Repeatedly buying a declining asset can increase losses when the original investment thesis is wrong.

I would want to see a clear limit on total exposure, a reason for each position and specific conditions that would invalidate the investment thesis.

The amount of money available is not a substitute for risk management.

5. What would convince me that a real recovery is developing?

I would watch for evidence beyond one investor's purchases:

Chinese technology stocks beginning to stabilize rather than repeatedly making lower lows.

Improving trading breadth, with more companies participating in the recovery.

Earnings and revenue expectations holding up after the selloff.

Stronger domestic demand and business confidence.

Reduced pressure from international trade and technology restrictions.

A rebound accompanied by improving fundamentals is different from a short-lived rally driven mainly by bargain hunting.

My take

I respect the idea of preparing capital when other investors are forced to sell. But I would not copy a large investor's position simply because the number sounds impressive.

The more useful lesson is to understand the strategy: why these assets were selected, how much downside the investor can tolerate, and whether the buying is being spread across multiple price levels.

For me, the opportunity may be real, but the bottom is still something the market has to prove.

I would rather miss the first part of a rebound than commit too much capital before selling pressure has clearly weakened.

💬 If you had to make this decision today, would you build positions gradually in Chinese assets, wait for a confirmed recovery, or stay in cash? And between Zhongji Innolight and Tencent, which business would you be more comfortable holding through volatility?

Not financial advice.
@Gate_Square